Science Speaks: HIV & TB News
Search
Archive for April, 2010
Enhanced NIH Funding Vital For Success in Battle Against AIDS
If there’s any question about the value of U.S. investments in scientific research on HIV/AIDS, Anthony Fauci probably put it to rest today by noting that in the period since HIV first emerged, “we went from a 26-week lifespan to a 40-year-plus life span” for those infected with the virus. Talk about measureable outcomes. That [...]
Top Physician-Scientists Voice Grave Concern about Stagnant U.S. Global AIDS and TB Funding
Nearly 300 leading U.S. disease experts expressed serious concern about the White House’s inadequate budget request for global AIDS and TB programs, saying the proposed funding levels signal a retreat in the U.S. response to the twin epidemics of HIV and TB. In a strongly-worded letter sent to members of Congress today, the physician-scientists said [...]
Join Effort to Rebuild World Commitment to Global AIDS Fight
With an eye toward rebuilding international commitment to combating global AIDS, the International AIDS Society (IAS) has created a new online tool to help scientists and other HIV advocates pressure their leaders to live up to Universal Access goals at upcoming G8 & G20 meetings. With this e-advocacy campaign, individuals can click here to send [...]
South Africa Steps Up on AIDS, But Are Goals Reachable if World Steps Back?
This excellent New York Times story makes clear that, when it comes to battling AIDS, it really is a new day in South Africa. But even as the South African government unveils an impressive new plan to ramp up HIV treatment and prevention, a new report from the International Treatment Prepardness Coalition makes it equally clear that [...]
Save the Date: Briefing on Stemming the Deadly Twin Epidemics of HIV and Tuberculosis
As U.S. policymakers prepare to make key decisions about global health spending amid an unfolding crisis in access to HIV treatment in Africa, a group of the nation’s leading scientists and advocates will gather to discuss the opportunities and challenges for combating the deadly dual epidemics of HIV and TB. Join Anthony Fauci, MD, director [...]
Global Fund Chief Says U.S. Needs to Make High-Level Long-Term Commitment
The full-court press is on for Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. With the Global Fund’s replenishment conference set for early October, “this must be an intensive period of advocacy of all of us,” he told a group of D.C.-based global health advocates on Wednesday. One of [...]
HIV Treatment Access in Uganda: A Report from the Ground
Asia Russell, director of international policy for Health GAP, is currently in Uganda gathering first-hand accounts of the unfolding crisis in access to HIV treatment caused by stagnant funding for global AIDS programs, program realignment, the worldwide recession, and other problems. What follows is a sampling of what she has found so far, from a [...]
Guest Blog: GHI May Unravel PEPFAR's Success
Last week, the Kaiser Family Foundation held a forum on the Obama Administration’s Global Health Initiative, sparking fresh debate over this significant shift in U.S. global health policy. In response to the presentations made by top U.S. government officials at that event, Shepherd Smith, a well-known AIDS advocate and program coordinator with considerable knowledge about [...]
A Unique Perspective on Flat-Funding From a Clinician, Activist, and HIV-Positive Woman
Lydia Mungherera knows better than most people what’s at stake in the unfolding crisis over global AIDS funding. She is a medical doctor, an activist, and woman living with AIDS, and she’s growing increasingly concerned about the ramifications of flat-funding for the President’s Emergency Plan for AIDS Relief, a cornerstone of the international response to [...]
Taking Next Steps Towards an AIDS Vaccine After Thai Trial
Last month, HIV scientists gathered for the Keystone Symposia on HIV Pathogenesis, where research results highlighted continued momentum in the search for an effective HIV vaccine. The current positive outlook among vaccine researchers is based in part on the modest efficacy data of RV144, the vaccine that completed testing in Thailand last year. This was [...]
Follow us
